Effect of melatonin on neurological status and oxidative modification of proteins in experimental cerebral ischemia
Acta Biomedica Scientifica · 02.08.2026 · 11 (3) · 154-161
DOI: 10.29413/abs.2026-11.3.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomedica Scientifica, online erschienen am 02.08.2026. Verfasst von M. V. Osikov und 3 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Ischemic stroke (IS) remains one of the leading causes of death and disability worldwide. Due to the limitations of oral and parenteral routes of neuroprotectant administration in post-stroke patients, the use of rectal suppositories with melatonin (MT) is a promising direction for neuroprotective therapy.
Aim
To evaluate the effect of rectal suppositories containing MT on the dynamics of neurological status and products of oxidative protein modification in experimental acute cerebral ischemia (EACI). Materials and methods . Male Wistar rats (n = 30) were divided into 3 groups: I – sham-operated animals; II – animals with EACI according to the method of Chen S.T. et al.; III – animals with EACI that received rectal suppositories weighing 100 mg, containing 2.5 mg of MT. Neurological status was assessed on days 3 and 7 using the Garcia J.N. scale, the paw placement test, and the Bederson test. In the ischemic focus of the brain (IFB), the content of early and late products of protein oxidative modification (POM) was evaluated.
Results
In rats with EACI, neurological deficits developed on the corresponding day (decreased scores on the Garcia J.N. scale and the paw placement test, increased scores on the Bederson test) and an increase in the content of POM products in the IFB. Administration of MT suppositories contributed to the regression of these disorders: by day 7, there was an improvement in all neurological tests, and a decrease in POM products in the IFB.
Conclusions
The results obtained suggest that the neuroprotective effect of MT in the form of rectal suppositories in EACI is mediated through an antioxidant mechanism of action.
Zitieren
APA
Osikov, M. V., Shelomentsev, A. V., Shishkova, Y. S., & Fedosov, A. A. (2026). Effect of melatonin on neurological status and oxidative modification of proteins in experimental cerebral ischemia. Acta Biomedica Scientifica, 11(3), 154-161. https://doi.org/10.29413/abs.2026-11.3.19
Vancouver
Osikov MV, Shelomentsev AV, Shishkova YS, Fedosov AA. Effect of melatonin on neurological status and oxidative modification of proteins in experimental cerebral ischemia. Acta Biomedica Scientifica. 2026;11(3):154-161. doi:10.29413/abs.2026-11.3.19
BibTeX
@article{Osikov2026,
author = {Osikov, M. V. and Shelomentsev, A. V. and Shishkova, Yu. S. and Fedosov, A. A.},
title = {Effect of melatonin on neurological status and oxidative modification of proteins in experimental cerebral ischemia},
journal = {Acta Biomedica Scientifica},
year = {2026},
volume = {11},
number = {3},
pages = {154--161},
doi = {10.29413/abs.2026-11.3.19}
}
EUVIMED